Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 308
- Registration Number
- NCT00048971
- Locations
- πΊπΈ
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
πΊπΈCedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈRebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 80
- Registration Number
- NCT00052845
- Locations
- πΊπΈ
Walter Reed Army Medical Center, Washington, District of Columbia, United States
π¨π¦McGill University, Montreal, Quebec, Canada
πΊπΈCedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 30
- Registration Number
- NCT00031980
- Locations
- πΊπΈ
Roswell Park Cancer Institute, Buffalo, New York, United States
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 64
- Registration Number
- NCT00049127
- Locations
- πΊπΈ
Illinois CancerCare Galesburg, Galesburg, Illinois, United States
πΊπΈMason District Hospital, Havana, Illinois, United States
πΊπΈMcdonough District Hospital, Macomb, Illinois, United States
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 39
- Registration Number
- NCT00045591
- Locations
- πΊπΈ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
πΊπΈCedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈMemorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 3871
- Registration Number
- NCT00041119
- Locations
- πΊπΈ
UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States
πΊπΈBismarck Cancer Center, Bismarck, North Dakota, United States
πΊπΈDubs Cancer Center at Rogue Valley Medical Center, Medford, Oregon, United States
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-19
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 65
- Registration Number
- NCT00033696
- Locations
- πΊπΈ
Cedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈCCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
πΊπΈUniversity of Massachusetts Memorial Medical Center - University Campus, Worcester, Massachusetts, United States
Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 60
- Registration Number
- NCT00042965
- Locations
- πΊπΈ
Cedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈMBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States
πΊπΈVeterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 91
- Registration Number
- NCT00006029
- Locations
- πΊπΈ
Memorial Regional Hospital Comprehensive Cancer Center, Hollywood, Florida, United States
πΊπΈUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
πΊπΈFort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States
Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 129
- Registration Number
- NCT00003611
- Locations
- πΊπΈ
CentraCare Health Plaza, Saint Cloud, Minnesota, United States
πΊπΈCCOP - Wichita, Wichita, Kansas, United States
πΊπΈCCOP - Carle Cancer Center, Urbana, Illinois, United States